Sector consensus Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE Other stock markets 01:30:00 29/07/2026 am IST			5-day change	1st Jan Change
2.870 ^USD	+1.77%		-1.71%	+4.36%

28/07	Perspective Therapeutics' Neuroendocrine Tumor Therapy Receives EU Orphan Drug Designation	MT
17/07	Perspective Therapeutics Data On 212Pb VMT-a-NET Accepted For Oral Presentation At ESMO Congress 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
PERSPECTIVE THERAPEUTICS, INC.	12.93	+358.63%	15
LONZA GROUP AG	678.91	+21.36%	23
REVOLUTION MEDICINES, INC.	207	+10.07%	21
BEONE MEDICINES AG	415.64	+27.54%	27
IQVIA HOLDINGS INC.	232	+8.81%	19
CELLTRION, INC.	2,61,962.3	+46.59%	24
ASCENDIS PHARMA A/S	267.77	+20.14%	18
MEDPACE HOLDINGS, INC.	570.67	-3.17%	12
EUROFINS SCIENTIFIC SE	72.17	+7.85%	14
ICON PUBLIC LIMITED COMPANY	181.81	+7.72%	16
BIO-TECHNE CORPORATION	70	-2.26%	12
ABIVAX	138.56	+22.4%	6
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	230.93	+2.96%	15
APOGEE THERAPEUTICS, INC.	130.53	-2.79%	12
PHARMARON BEIJING CO., LTD.	37.73	-2.68%	11
IONIS PHARMACEUTICALS, INC.	91.65	+63.78%	20
KYMERA THERAPEUTICS, INC.	127.52	+15.88%	21
PRAXIS PRECISION MEDICINES, INC.	610.05	+93.18%	19
ALKERMES PLC	54.88	+4.08%	17
PROTAGONIST THERAPEUTICS, INC.	133.31	-1.66%	13
Average	13,311.32	+34.92%	17
Weighted average by Cap.	21,510.56	+18.62%	19